POEMS Syndrome Treatment With Lenalidomide

PHASE2CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

June 30, 2018

Study Completion Date

July 31, 2018

Conditions
POEMS Syndrome
Interventions
DRUG

Lenalidomide and dexamethasone

2 cycles of the lenalidomide-dexamethasone (Len-Dex) combination before radiation or intensive treatment

DRUG

Lenalidomide and dexamethasone

9 cycles of the Len-Dex combination

Trial Locations (11)

14000

CHU de Caen, Caen

31059

CHU de Toulouse, Toulouse

44093

CHU de Nantes, Nantes

49933

CHU d'Angers, Angers

59037

CHU de Lille, Lille

69000

Hospices Civil de Lyon, Lyon

69373

Centre Léon Bérard, Lyon

75010

Hôpital Saint-Louis, Paris

75013

Pitié Salpétrière, Paris

75743

Hôpital Necker, Paris

87042

CHU de Limoges, Limoges

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Ministry of Health, France

OTHER_GOV

collaborator

Celgene Corporation

INDUSTRY

lead

University Hospital, Limoges

OTHER

NCT01639898 - POEMS Syndrome Treatment With Lenalidomide | Biotech Hunter | Biotech Hunter